Postma F R, Jalink K, Hengeveld T, Moolenaar W H
Division of Cellular Biochemistry, The Netherlands Cancer Institute, Netherlands.
EMBO J. 1996 May 15;15(10):2388-92.
Sphingosine-1-phosphate (S1P) is a bioactive lysosphingolipid implicated in mitogenesis and cytoskeletal remodelling, but its mechanism of action is poorly understood. We report here that in N1E-115 neuronal cells, S1P mimics the G protein-coupled receptor agonist lysophosphatidic acid (LPA) in rapidly inducing neurite retraction and soma rounding, a process driven by Rho-dependent contraction of the actin cytoskeleton. S1P is approximately 100-fold more potent than LPA in evoking these shape changes, with an EC50 as low as 1.5 nM. Microinjection of S1P has no effect, neither has addition of sphingosine or ceramide. As with LPA, S1P action is inhibited by suramin and subject to homologous desensitization; however, the responses to S1P and LPA do not show cross-desensitization. We conclude that S1P activates its own high affinity receptor to trigger Rho-regutated cytoskeletal events. Thus, S1P and LPA may belong to an emerging family of bioactive lysophospholipids that act through distinct G protein-coupled receptors to mediate similar actions.
鞘氨醇-1-磷酸(S1P)是一种参与有丝分裂和细胞骨架重塑的生物活性溶血鞘脂,但其作用机制尚不清楚。我们在此报告,在N1E-115神经细胞中,S1P模拟G蛋白偶联受体激动剂溶血磷脂酸(LPA),迅速诱导神经突回缩和胞体变圆,这一过程由肌动蛋白细胞骨架的Rho依赖性收缩驱动。在引发这些形状变化方面,S1P的效力比LPA高约100倍,其半数有效浓度(EC50)低至1.5 nM。显微注射S1P无效,添加鞘氨醇或神经酰胺也无效。与LPA一样,S1P的作用受到苏拉明抑制并会发生同源脱敏;然而,对S1P和LPA的反应并未表现出交叉脱敏。我们得出结论,S1P激活其自身的高亲和力受体以触发Rho调节的细胞骨架事件。因此,S1P和LPA可能属于一个新兴的生物活性溶血磷脂家族,它们通过不同的G蛋白偶联受体发挥作用,介导相似的作用。